Cavalier Investments’s Johnson & Johnson JNJ Stock Holding History

Cavalier Investments’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-7,842	Closed	-$1.01M	–	144
2018 Q4	$1.01M	Buy	+7,842	New	+$1.09M	0.33%	65
2018 Q2	–	Sell	-495	Closed	-$63K	–	177
2018 Q1	$63K	Buy	+495	New	+$66.9K	0.02%	167

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cavalier Investments's JNJ Position: Q1 2019 in Review

Cavalier Investments sold out of Johnson & Johnson (JNJ) in Q1 2019, closing a stake of 7,842 shares — an estimated $1.01M sold.

Cavalier Investments first reported a position in JNJ in Q1 2018 and held it in 2 quarters. The position peaked at $1.01M in Q4 2018. 2,766 funds tracked by Wall St. Rank hold JNJ as of Q1 2019.

Cavalier Investments reported no remaining Johnson & Johnson position as of Q1 2019 after selling out during the quarter.
Cavalier Investments sold 7,842 Johnson & Johnson shares in Q1 2019, an estimated $1.01M.
Cavalier Investments first reported a position in Johnson & Johnson in Q1 2018 and held it in 2 quarters.
Cavalier Investments's Johnson & Johnson position peaked at $1.01M in Q4 2018.
2,766 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2019.

Based on Cavalier Investments's 13F filing for Q1 2019, filed 3 May 2019.